(Q41355170)

29 September 2017

title

DR4Dw4/DR53 molecules contain a peptide from the autoantigen calreticulin (English)

1 reference

29 September 2017

7

F. Koning

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7638864

3 July 2024

author name string

F. A. Verreck

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7638864

3 July 2024

D. Elferink

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7638864

3 July 2024

C. J. Vermeulen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7638864

3 July 2024

R. Amons

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7638864

3 July 2024

F. Breedveld

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7638864

3 July 2024

R. R. de Vries

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7638864

3 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7638864

3 July 2024

publication date

1 April 1995

1 reference

full work available at URL

29 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1399-0039.1995.tb02451.x

1 reference

https://api.crossref.org/works/10.1111/J.1399-0039.1995.TB02451.X

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1399-0039.1995.tb02451.x

3 July 2024

1 reference

https://api.crossref.org/works/10.1111/J.1399-0039.1995.TB02451.X

3 July 2024

1 reference

29 September 2017

volume

45

1 reference

29 September 2017

issue

4

1 reference

29 September 2017

page(s)

270-275

1 reference

Structure of peptides associated with MHC class I molecules.

29 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1111/J.1399-0039.1995.TB02451.X

Origin, structure and motifs of naturally processed MHC class II ligands

3 July 2024

2

1 reference

https://api.crossref.org/works/10.1111/J.1399-0039.1995.TB02451.X

Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules

3 July 2024

3

1 reference

https://api.crossref.org/works/10.1111/J.1399-0039.1995.TB02451.X

Self-peptide released from class II HLA-DR1 exhibits a hydrophobic two-residue contact motif

3 July 2024

5

1 reference

https://api.crossref.org/works/10.1111/J.1399-0039.1995.TB02451.X

Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size

3 July 2024

6

1 reference

https://api.crossref.org/works/10.1111/J.1399-0039.1995.TB02451.X

Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles

3 July 2024

8

1 reference

https://api.crossref.org/works/10.1111/J.1399-0039.1995.TB02451.X

Identification of a motif for HLA-DR1 binding peptides using M13 display libraries

3 July 2024

10

1 reference

https://api.crossref.org/works/10.1111/J.1399-0039.1995.TB02451.X

Promiscuous and allele-specific anchors in HLA-DR-binding peptides

3 July 2024

11

1 reference

https://api.crossref.org/works/10.1111/J.1399-0039.1995.TB02451.X

Identification of an HLA-DQ2 peptide binding motif and HLA-DPw3-bound self-peptide by pool sequencing

3 July 2024

13

1 reference

https://api.crossref.org/works/10.1111/J.1399-0039.1995.TB02451.X

Pool sequencing of natural HLA-DR, DQ, and DP ligands reveals detailed peptide motifs, constraints of processing, and general rules

3 July 2024

14

1 reference

https://api.crossref.org/works/10.1111/J.1399-0039.1995.TB02451.X

T cell recognition as the target for immune intervention in autoimmune disease

3 July 2024

15

1 reference

https://api.crossref.org/works/10.1111/J.1399-0039.1995.TB02451.X

Association of the B-cell alloantigen DRw4 with rheumatoid arthritis

3 July 2024

16

1 reference

https://api.crossref.org/works/10.1111/J.1399-0039.1995.TB02451.X

Isolation of an HLA-A2.1 extracted human minor histocompatibility peptide

3 July 2024

17

1 reference

https://api.crossref.org/works/10.1111/J.1399-0039.1995.TB02451.X

Distinct HLA-DR epitopes and distinct families of HLA-DR molecules defined by 15 monoclonal antibodies (mAb) either anti-DR or allo-anti-Iak crossreacting with human DR molecule. I. Cross-inhibition studies of mAb cell surface fixation and differenti

3 July 2024

18

1 reference

https://api.crossref.org/works/10.1111/J.1399-0039.1995.TB02451.X

Calreticulin synthetic peptide analogues: anti-peptide antibodies in autoimmune rheumatic diseases.

3 July 2024

20

1 reference

https://api.crossref.org/works/10.1111/J.1399-0039.1995.TB02451.X

Systemic lupus erythematosus is associated with increased auto-antibody titers against calreticulin and grp94, but calreticulin is not the Ro/SS-A antigen

3 July 2024

21

1 reference

https://api.crossref.org/works/10.1111/J.1399-0039.1995.TB02451.X

3 July 2024

Identifiers

1 reference

29 September 2017

1 reference